Davana ether

Details

Top
Internal ID f0afc2ff-3d64-4f46-847f-2d458ab52a58
Taxonomy Organoheterocyclic compounds > Tetrahydrofurans
IUPAC Name (5E)-5-[1-(5-ethenyl-5-methyloxolan-2-yl)ethylidene]-2,2-dimethylfuran
SMILES (Canonical) CC(=C1C=CC(O1)(C)C)C2CCC(O2)(C)C=C
SMILES (Isomeric) C/C(=C\1/C=CC(O1)(C)C)/C2CCC(O2)(C)C=C
InChI InChI=1S/C15H22O2/c1-6-15(5)10-8-13(17-15)11(2)12-7-9-14(3,4)16-12/h6-7,9,13H,1,8,10H2,2-5H3/b12-11+
InChI Key ZFMNPTVNDZBEHA-VAWYXSNFSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O2
Molecular Weight 234.33 g/mol
Exact Mass 234.161979940 g/mol
Topological Polar Surface Area (TPSA) 18.50 Ų
XlogP 3.30
Atomic LogP (AlogP) 3.75
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 2

Synonyms

Top
ZFMNPTVNDZBEHA-VAWYXSNFSA-N
35470-57-6
Q67879823
5-[(1E)-1-(5,5-Dimethyl-2(5H)-furanylidene)ethyl]-2-methyl-2-vinyltetrahydrofuran
5-[(1E)-1-(5,5-Dimethyl-2(5H)-furanylidene)ethyl]-2-methyl-2-vinyltetrahydrofuran #

2D Structure

Top
2D Structure of Davana ether

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9889 98.89%
Caco-2 + 0.7174 71.74%
Blood Brain Barrier + 0.9250 92.50%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.3287 32.87%
OATP2B1 inhibitior - 0.8609 86.09%
OATP1B1 inhibitior + 0.8970 89.70%
OATP1B3 inhibitior + 0.9054 90.54%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.9075 90.75%
P-glycoprotein inhibitior - 0.9145 91.45%
P-glycoprotein substrate - 0.8386 83.86%
CYP3A4 substrate + 0.5724 57.24%
CYP2C9 substrate - 0.5872 58.72%
CYP2D6 substrate - 0.7677 76.77%
CYP3A4 inhibition - 0.8825 88.25%
CYP2C9 inhibition - 0.7442 74.42%
CYP2C19 inhibition - 0.6174 61.74%
CYP2D6 inhibition - 0.9242 92.42%
CYP1A2 inhibition - 0.5077 50.77%
CYP2C8 inhibition + 0.4700 47.00%
CYP inhibitory promiscuity - 0.6845 68.45%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7528 75.28%
Carcinogenicity (trinary) Non-required 0.4576 45.76%
Eye corrosion - 0.8788 87.88%
Eye irritation - 0.6592 65.92%
Skin irritation + 0.5712 57.12%
Skin corrosion - 0.9265 92.65%
Ames mutagenesis - 0.5570 55.70%
Human Ether-a-go-go-Related Gene inhibition + 0.7714 77.14%
Micronuclear - 0.9200 92.00%
Hepatotoxicity + 0.6055 60.55%
skin sensitisation + 0.7249 72.49%
Respiratory toxicity - 0.6333 63.33%
Reproductive toxicity - 0.6667 66.67%
Mitochondrial toxicity - 0.7000 70.00%
Nephrotoxicity + 0.5533 55.33%
Acute Oral Toxicity (c) III 0.6911 69.11%
Estrogen receptor binding - 0.6577 65.77%
Androgen receptor binding - 0.8001 80.01%
Thyroid receptor binding + 0.5222 52.22%
Glucocorticoid receptor binding - 0.6161 61.61%
Aromatase binding - 0.7828 78.28%
PPAR gamma - 0.6835 68.35%
Honey bee toxicity - 0.8010 80.10%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity + 0.6000 60.00%
Fish aquatic toxicity + 0.6571 65.71%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.23% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.69% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.59% 94.45%
CHEMBL1951 P21397 Monoamine oxidase A 87.17% 91.49%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.61% 100.00%
CHEMBL241 Q14432 Phosphodiesterase 3A 84.12% 92.94%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.00% 95.89%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.42% 89.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 81.33% 97.25%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Chrysanthemum indicum

Cross-Links

Top
PubChem 5370105
NPASS NPC283388
LOTUS LTS0157757
wikiData Q67879823